Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in SLS — SELLAS Life Sciences Group, Inc.

CIK 1390777 NEW YORK, NY
Back to SLS Full portfolio

Position in SLS

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$7,823,166
+$5,799,679 QoQ
Shares Held
530,025
+10.8% QoQ
Ownership
0.262%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#19
of 192 holders
Holding Since
Mar 2020
21 quarters on record
Voting authority Sole 84% Shared 0% None 16%

Common Shares in SLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. SLS ranks #77 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in SLS

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $7,823,166 530,025
2026-03-31 $2,023,487 478,366
2025-12-31 $966,660 256,409
2025-09-30 $331,147 205,682
2025-06-30 $441,197 201,460
2023-12-31 $89,744 84,665
2023-09-30 $33,478 20,414
2023-06-30 $32,565 20,743
2023-03-31 $29,789 20,832
2022-12-31 $49,163 20,832
2022-09-30 $40,898 20,247
2022-06-30 $45,150 20,247
2022-03-31 $140,126 20,977
2021-12-31 $116,002 20,977
2021-09-30 $192,149 20,977
2021-06-30 $225,685 20,332
2021-03-31 $133,257 15,604
2020-12-31 $93,593 16,109
2020-09-30 $42,688 16,109
2020-06-30 $47,199 16,109
2020-03-31 $27,868 16,109